We are live on ! Find out more
VCYT icon

Veracyte

80 hedge funds and large institutions have $137M invested in Veracyte in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 22 increasing their positions, 28 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 8

1% more funds holding

Funds holding: 7980 (+1)

0.87% more ownership

Funds ownership: 70.99%71.86% (+0.87%)

13% less capital invested

Capital invested by funds: $158M → $137M (-$20.8M)

21% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 28

33% less funds holding in top 10

Funds holding in top 10: 32 (-1)

97% less call options, than puts

Call options by funds: $17K | Put options by funds: $638K

Holders
80
Holders Change
+1
Holders Change %
+1.27%
% of All Funds
1.83%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
9
Increased
22
Reduced
28
Closed
8
Calls
$17K
Puts
$638K
Net Calls
-$621K
Net Calls Change
+$318K

VCYT Hedge Fund Activity: Q1 2018 in Review

80 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q1 2018, worth a combined $137M — down 13% from $158M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new VCYT positions and 8 closed out — a net gain of 1 holder — while 22 added to existing stakes and 28 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $8.72M. The largest seller was Avoro Capital Advisors, cutting an estimated $3.92M.

  • 80 institutional investors held Veracyte (VCYT) as of Q1 2018, up from 79 in Q4 2017.
  • Funds reported $137M of Veracyte stock for Q1 2018, down 13% quarter-over-quarter.
  • 9 funds opened new Veracyte positions in Q1 2018 and 8 closed out, a net change of +1 holder.
  • The largest Veracyte buyer in Q1 2018 was ARK Investment Management, an estimated $8.72M added.
  • The largest Veracyte seller in Q1 2018 was Avoro Capital Advisors, an estimated $3.92M sold.

Based on aggregated 13F filings for Q1 2018.